Team discovers novel drug target for Alzheimer’s and related dementias

April 14, 2022

Researchers from UT Health San Antonio today reported the discovery of a novel mechanism by which pathological forms of tau protein cause neurons to die. Alzheimer’s disease and chronic traumatic encephalopathy (CTE) are among more than 20 disorders that include tau protein pathology. The newly found mechanism of tau-induced damage can be altered pharmacologically, the scientists noted, making it a novel target for drug development.

UT Health San Antonio schools receive national recognition

April 6, 2022

Released in March, the U.S. News and World Report’s list of best graduate schools for 2023 ranked the Long School of Medicine and the School of Nursing programs among the best in the country.

Restraining a liver enzyme could help us trim down, reduce appetite

April 6, 2022

In a breakthrough discovery, scientists at UT Health San Antonio reported that inhibiting a liver enzyme in obese mice decreased the rodents’ appetite, increased energy expenditure in fat tissues and resulted in weight loss.

The Center for Mucosal & Microbiome Biology at UT Health San Antonio

April 5, 2022

UT Health San Antonio recently introduced its newest research center, the Center for Mucosal & Microbiome Biology, located within the Joe R. and Teresa Lozano Long School of Medicine. Led by Mansour M. Zadeh, PhD, distinguished professor of medicine in the Division of Gastroenterology and Nutrition, the center will function as a collaborative entity for […]

Black patients with cancer fare worse with COVID-19, study shows

April 1, 2022

Structural racism, rather than disease, leads to inequities, authors write Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of the COVID-19 and Cancer Consortium (https://ccc19.org/), which includes more than 125 cancer centers and other organizations, studied […]